Status:

COMPLETED

Female Muscle Enhancement

Lead Sponsor:

University of Exeter

Collaborating Sponsors:

P.volve LLC

Conditions:

Muscle Function

Eligibility:

FEMALE

40-60 years

Phase:

NA

Brief Summary

Participating in regular physical activity has been shown to reduce the risk of developing some diseases and disabilities that can occur with ageing. Muscles naturally decline with age, and in females...

Eligibility Criteria

Inclusion

  • Females aged 40-60 years of age at time of screening.
  • Body mass index \<30kg/m2 and \>18.5kg/m2
  • Considered moderately active according to the 7 day International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003)
  • Self-reported as healthy (absence of injury or disease).
  • Availability and willingness to attended 12 weeks of exercises classes 4-5 times per week at St Luke's Campus Exeter and participate in the study lasting a total of 26 weeks.

Exclusion

  • Pregnant, lactating or planning a pregnancy.
  • Current diagnosis of a chronic disease such as diabetes, autoimmune disease, cardiovascular disease, kidney disease.
  • Hysterectomy and/or ovariectomy.
  • Currently prescribed hormone replacement therapy.
  • Hypertension (BP ≥149/90 mm/Hg)
  • Either current smoker, or history of smoking in the past 6 months.
  • Currently taking supplements that have been shown to impact muscle function and muscle mass, such as creatine, in the last 6 months.
  • Prescribed medications that have been shown to impact muscle function and muscle mass, such as steroids, in the last 6 months.
  • History of epilepsy.
  • Current or recent injury within the last 6 months that may affect their ability to carry out the resistance training program.
  • Advised not to exercise by their General Practitioner or medical professional.
  • Resistance training consistently for 3 or more times per week for the last 2 months

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 23 2023

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05397418

Start Date

May 1 2022

End Date

November 23 2023

Last Update

June 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Exeter

Exeter, United Kingdom, EX1 2LT